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Abstract. 
 
The promyelocytic leukemia (PML) nuclear 
body (also referred to as ND10, POD, and Kr body) is 
involved in oncogenesis and viral infection. This subnu-
clear domain has been reported to be rich in RNA and 
a site of nascent RNA synthesis, implicating its direct 
involvement in the regulation of gene expression. We 
used an analytical transmission electron microscopic 
method to determine the structure and composition of 
PML nuclear bodies and the surrounding nucleoplasm. 
Electron spectroscopic imaging (ESI) demonstrates 
that the core of the PML nuclear body is a dense, pro-
tein-based structure, 250 nm in diameter, which does 
not contain detectable nucleic acid. Although PML nu-
clear bodies contain neither chromatin nor nascent 
RNA, newly synthesized RNA is associated with the 
periphery of the PML nuclear body, and is found within 
the chromatin-depleted region of the nucleoplasm im-
mediately surrounding the core of the PML nuclear 
body. We further show that the RNA does not accumu-
late in the protein core of the structure. Our results dis-
miss the hypothesis that the PML nuclear body is a site 
of transcription, but support the model in which the 
PML nuclear body may contribute to the formation of a 
favorable nuclear environment for the expression of 
speciﬁc genes.
Key words: transcription • nuclear structure • acety-
lated chromatin • correlative microscopy • electron 
spectroscopic imaging
 
Introduction
 
The promyelocytic leukemia (PML)
 
1
 
 nuclear body is a nu-
clear matrix-associated structure 250–500 nm in diameter
that is present in the nucleus of most cell lines (Ascoli and
Maul, 1991; De Graaf et al., 1992; Stuurman et al., 1992;
Chang et al., 1995; Grande et al., 1996). There are approx-
imately ten of these structures per nucleus, though this can
vary considerably depending on the cell type, cell cycle,
and other factors (Ascoli and Maul, 1991). The first bio-
chemical component to be identified was the Sp100 nu-
clear matrix associated protein, which is an autoantigen in
some patients with primary biliary cirrhosis (Szostecki et
al., 1990). This protein has been found to trans-activate a
variety of promoters (Guldner et al., 1992; Xie et al., 1993)
and has an MHC class I-like domain at its NH
 
2
 
 terminus
(Sternsdorf et al., 1997a). The promyelocytic leukemia
gene product, PML, is also found in PML nuclear bodies.
In some acute promyelocytic leukemias, a t(15;17) chro-
mosomal translocation creates a fusion protein of PML
and the retinoic acid receptor alpha (Borrow et al., 1990;
de The et al., 1990, 1991; Kakizuka et al., 1991; Dyck et al.,
1994; Koken et al., 1994). PML protein may have tran-
scription regulation activity (Xie et al., 1993; Vallian et al.,
1997, 1998a,b), may suppress growth and transformation
(Le et al., 1996; Fagioli et al., 1998), and is implicated in
apoptosis (Wang et al., 1998). Int-6 is another protein that
may localize to the PML nuclear body, reported in the
context of studies of the HTLV-1 virus (Desbois et al.,
1996). A ubiquitin homologue, PIC1/SUMO-1 can be co-
valently bound to PML and Sp100 protein, and partially
colocalizes with the PML nuclear body (Sternsdorf et al.,
1997b, 1999). This posttranslational modification has been
proposed to be responsible for the targeting of proteins to
the PML nuclear domain (Muller et al., 1998; Duprez et al.,
1999).
PML nuclear bodies are also a target of a variety of vi-
ruses, and are thought to be involved in coordinating the
expression and replication of viral genomes from phyloge-
netically distinct families (for a review, see Sternsdorf et al.,
1997a). A number of DNA viruses, such as SV40, Ad5,
and HSV-1, begin replication in the vicinity of a few, but
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not all, of the PML bodies in a nucleus. Increased amounts
of infectious virus in a cell do not result in an increase in
the number of nuclear sites of viral replication. This im-
plies that PML nuclear bodies may not be identical (De
Bruyn-Kops and Knipe, 1994; Maul, 1998). Viral protein
expression does not appear to be necessary for targeting
viral genomes to these replication sites (Ishov and Maul,
1996). Transcription of the viral genome also takes place
at the periphery of the PML nuclear bodies, perhaps be-
cause they create a suitable environment (Ishov et al.,
1997; Maul, 1998). Finally, many viruses disassemble or
degrade PML nuclear bodies before proceeding to the late
phase in infection cycles (Doucas et al., 1996; Maul et al.,
1996; Ishov et al., 1997; Maul, 1998). This may have a dis-
ruptive effect on host nuclear function.
The cellular role of the PML nuclear body remains un-
certain, despite its obvious links to oncogenesis and viral
infection (for reviews, see Sternsdorf et al., 1997a; Slack
and Gallagher, 1999). PML nuclear bodies may be sites of
storage of transcription factors, sites of transcription, or
sites of RNA accumulation. The presence of RNA, by flu-
orescein-UTP microinjection and EDTA-regressive stain-
ing, has been observed within the structure of the PML nu-
clear body (LaMorte et al., 1998), indicating a potential
role in the transcription of some genes. The high enrich-
ment of the transcriptional coactivator/histone acetyl-
transferase, CBP, is further suggestive of transcriptional
activity within this domain (LaMorte et al., 1998; Doucas
et al., 1999). Consequently, it is important to understand
the composition of these structures and the composition
and organization of the surrounding nucleoplasm. In this
study, we used both indirect immunofluorescence micros-
copy and a novel analytical transmission electron micro-
scope method, electron spectroscopic imaging (ESI), to
address the composition of PML nuclear bodies. PML nu-
clear bodies did not stain with antibodies recognizing highly
acetylated histones nor those recognizing fluorine-substi-
tuted uridine (FU). Furthermore, phosphorus mapping by
ESI rules out the presence of chromatin or RNA within
these structures. However, nascent RNA can be detected
at the periphery, indicating that the surroundings of the
PML nuclear bodies are sites of transcriptional activity.
 
Materials and Methods
 
Immunodetection of Nascent RNA and PML
Nuclear Bodies
 
SK-N-SH cells were cultured directly on glass coverslips under conditions
recommended by the American Type Culture Collection. Pulses of FU
were performed by addition of FU to a final concentration of 2 mM in the
culture medium. Cells were fixed with 1.0% paraformaldehyde in PBS,
pH 7.5, at room temperature for 5 min. Subsequently, cells were perme-
abilized in PBS containing 0.5% Triton X-100 for 5 min. Antibodies
against halogenated UTP (anti-BrdU; Sigma Chemical Co., catalog no.
B-2531) were used to label nascent RNA. Acetylated chromatin was visu-
alized using an antibody recognizing diacetylated histones H3 (Upstate
Biotechnology, Inc., catalog no. 06-599). PML nuclear bodies were visual-
ized using an anti-CBP NH
 
2
 
-terminal antibody (Santa Cruz, catalog no.
sc-369; or Upstate Biotechnology, Inc., catalog no. 06-297) or an anti-PML
antibody (5E10; Stuurman et al., 1992). Cells were then incubated with
secondary antibody, goat anti–rabbit Cy3 (Chemicon International, Inc.)
and goat anti–mouse (Alexa 488, Cedarlane Labs; or Cy2, Nycomed Am-
ersham, Inc.). After rinsing, the samples were mounted in 1 mg/ml para-
 
phenylenediamine in PBS/90% glycerol, containing DNA-specific staining
DAPI (4
 
9
 
,6-diamidino-2-phenylindole) at 1 
 
m
 
g/ml. Digital deconvolution
to reduce haze in optical sections was performed using a 14-bit cooled
CCD camera (Princeton Instruments) mounted on a Leica DMRE immu-
nofluorescence microscope. VayTek Microtome digital deconvolution
software was used to remove out of focus contributions, and image stacks
were projected into one image plane using Scion Image software. False
coloring and superimposition was done with Adobe Photoshop 5.0.
 
Correlative Microscopy and Electron Microscopy
 
Detailed descriptions of the EM procedure are presented elsewhere (Ba-
zett-Jones and Hendzel, 1999). In brief, cells were grown on polypropyl-
ene caps, fixed with 1.0% paraformaldehyde in PBS, and labeled for im-
munofluorescence as described above. Cells were then refixed in 2%
glutaraldehyde in PBS for 5 min, dehydrated in ethanol, starting at 30%,
before embedding in Quetol 651 resin. We have found that this fixation
procedure preserves fine structural detail in chromatin. Moreover, chro-
matin-based and protein-based fibers are routinely observed (Bazett-
Jones and Hendzel, 1999; Bazett-Jones et al., 1999; Hendzel et al., 1999).
To reveal the detail seen with this protocol, a section from the same block
as that used for data in this paper was stained with uranyl acetate and im-
aged in bright-field (Fig. 1, A and B). Elastic images recorded at 0-eV en-
ergy loss reveal well preserved heterochromatin masses along the nuclear
envelope. Fine structural detail is particularly evident in the high magnifi-
cation, uranium-enhanced image (recorded at 120 eV) of the region indi-
cated in Fig. 1 C.
Sections of 
 
z
 
30- and 90-nm thickness were obtained by ultramicrot-
omy with a diamond knife (Drukker), and were picked up onto finder
grids. These lettered grids allow particular cells in the section, first imaged
in the fluorescent microscope, to easily be found later in the electron mi-
croscope. Electron micrographs were obtained with a Gatan 14-bit slow
scan cooled CCD detector on a Zeiss EM 902 transmission electron mi-
croscope equipped with an imaging spectrometer (Bazett-Jones and
Hendzel, 1999). All images were corrected by dark current subtraction be-
fore being used for analysis. Energy filtered images recorded before an in-
ner shell ionization edge do not contain element-specific information, but
serve as a reference for the element-enhanced image recorded at an en-
ergy loss on, or just beyond, the inner shell ionization edge. In the case of
phosphorus imaging, for example, an image recorded at an energy loss of
120 eV serves as a reference for the phosphorus-enhanced image recorded
at 155 eV. A phosphorus map can be formed by subtracting the 120-eV
image from the 155-eV image, after alignment to within a pixel, and nor-
malization of the two images on a region that is known not to contain
phosphorus; or, by dividing the 155-eV image by the 120-eV image after
alignment of the two images. Similarly, a reference image for nitrogen is
recorded at 385 eV and the nitrogen-enhanced image is recorded at an en-
ergy loss of 415 eV (Bazett-Jones and Hendzel, 1999). The sections are
preirradiated before the images are recorded. Preirradiation stabilizes the
section and produces a state of terminal mass loss. Therefore, no mass loss
occurs during the recording of the complete set of reference and element-
enhanced images. All images are recorded with nearly equal exposures
measured over the background resin to insure equal signal counting statis-
tics at the detector level for all images (Bazett-Jones and Hendzel, 1999;
Bazett-Jones et al., 1999).
Examples of reference, element-enhanced, and element maps for phos-
phorus and nitrogen are shown in Fig. 1, D-I. Blocks of chromatin on the
nuclear envelope (top of image in Fig. 1, D–I), throughout the nucleo-
plasm, and at the surface of the nucleolus (Fig. 2, Nu), are clearly seen in
the phosphorus map. The granular component of the nucleolus has less
contrast than the blocks of chromatin, but more contrast than the nucleo-
plasm or the cytoplasm. Blocks of chromatin can also be seen in nitrogen
maps, but distinguishing chromatin from the granular component of the
nucleolus, for example, is more difficult because nitrogen is present in
both protein and nucleic acid. The granular component of the nucleolus
has a higher protein/nucleic acid ratio than that of chromatin.
In this paper we used the two window method (one reference image
and one post-edge, element-enhanced image) to obtain the elemental
maps. We have shown that unstained, 30–40-nm thick sections do not con-
tribute to detectable multiple scattering events or produce mass-density
artifacts in the net images (Bazett-Jones and Hendzel, 1999; Bazett-Jones
et al., 1999). It is always possible to find mass-dense structures, some of
which contain no detectable element, and others with high levels of that
element. Similarly, low mass-dense structures can be found that have ei-
ther no detectable element or high amounts. Mass-density artifacts in the 
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sections used in this study are only noticed where contaminating crystal-
lites of salts are imaged.
A 600-
 
m
 
m condenser aperture and a 90-
 
m
 
m objective aperture were
used. The energy-selecting slit aperture was set to correspond to 20 eV. To
measure the relative amount of phosphorus or nitrogen in various mor-
phologically defined structures in and around PML nuclear bodies, we
used the technique called image EELS (electron energy-loss spectros-
copy). Images of a selected field are collected at small steps (e.g., 10 eV) in
the energy-loss spectrum, spanning, for example, the phosphorus L
 
2,3
 
 and
nitrogen K edges. Masks are used to delineate objects of interest, and the
mean signals under these masks are measured in every image. If a struc-
ture contains phosphorus, a steep increase in the energy-loss spectrum
above 132 eV will emerge, along with a second steep increase beyond 150
eV, due to the delayed characteristic of this energy-loss event. The pres-
ence of nitrogen is more obvious than phosphorus, due to a sharper, less
delayed event beginning at 385 eV (see Bazett-Jones et al.,
 
 
 
1999). Mea-
Figure 1. Energy-filtered electron micrographs of a 90-nm section stained with uranyl acetate (A–C). Elastic images, collected at 0-eV
energy loss (A and B), show chromatin and other structures as black on a grey background. An energy-loss image recorded at a ura-
nium edge (120 eV; C) shows chromatin and other structures as white on a black background. The inset (43) shows a 10-nm-diam chro-
matin fiber with periodicity (vertical fiber at center of inset). Fibers of ,50% of this thickness are also prevalent in this section. An un-
stained section from the same block used in A–C was used to map phosphorus and nitrogen. A phosphorus reference image (120 eV;
D), a phosphorus-enhanced image (155eV; E), and a phosphorus map (F) are shown. Nitrogen reference (385 eV), enhanced (415 eV),
and map are shown (G–I, respectively). 
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surements of signal intensities in the masked regions were made with Er-
goVista 4.4 image analysis software.
 
Results
 
Structure of the PML Nuclear Body by
Correlative Microscopy
 
It has been reported that PML nuclear bodies are sites of
transcription and RNA accumulation (LaMorte et al.,
1998). We chose to test this model and to extend the
model to higher resolution by direct visualization without
using heavy atom contrast agents. We used ESI, a sensitive
TEM method, to map protein-based and nucleic acid-
based regions in and around PML nuclear bodies. One ad-
vantage of this technique is that comparisons of nitrogen
and phosphorus maps provide the ability to directly distin-
guish protein from nucleic acids in situ. Second, it is possi-
ble to quantify mass contributions from both the protein
and the nucleic acid components of a structure and to map
the spatial relationships of protein- and nucleic acid-based
structures within the complex nuclear environment (Ba-
zett-Jones and Hendzel, 1999). Third, the heavy atom con-
trast agents, which limit resolution and stain different bio-
chemical components in a nonuniform or predictable
manner, can be avoided.
Positive identification of PML nuclear bodies amongst
other nuclear structures with ESI alone is difficult. To
identify these structures definitively, we first labeled cells
with antibodies against the NH
 
2
 
 terminus of CBP, which
we have shown to colocalize with PML in PML nuclear
bodies in SK-N cells, by immunofluorescence microscopy.
Indeed, in this cell line, CBP is as reliable a marker of
PML nuclear bodies as for the PML protein itself. After
embedding and thin sectioning, the same section can first
be examined in the fluorescence microscope to identify
the location of PML nuclear bodies in individual cells. The
same section is then imaged at high resolution in the en-
ergy-filtering electron microscope (Bazett-Jones et al.,
1999). A thin section showing a nucleus imaged by immu-
nofluorescence is shown in Fig. 2 A. Five PML nuclear
bodies can easily be identified. Two are indicated (Fig. 2,
A, D, and E, arrows) near the nucleolus (Fig. 2 A, D, and
E, Nu). The same section imaged at 155-eV energy loss is
shown in Fig. 2 B at low magnification and superimposed
with the immunofluorescence image in Fig. 2 C, to corre-
late the fluorescently labeled structures with the underly-
ing ultrastructure. Two PML nuclear bodies are then de-
Figure 2. Correlative micros-
copy. Cells were labeled with
anti–CBP-NT antibody,
embedded, and sectioned.
Sections are first imaged by
immunofluorescence micros-
copy (A), followed by EM
using ESI (B). The images
are resized and rotated for
proper alignment before be-
ing merged (C). Structures
are represented as white ob-
jects on a black background.
Immunofluorescence micros-
copy also serves to identify
and locate structures of inter-
est, so that these can be ana-
lyzed at the ultrastructural
level by ESI, to map phos-
phorus (D) and nitrogen (E).
The region indicated by the
box in C is magnified in D
and E. Nu, Nucleolus; ar-
rows, the two PML nuclear
bodies from C. 
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tectable in the high magnification phosphorus (Fig. 2 D)
and nitrogen (Fig. 2 E) maps. The cores of each of these
nuclear bodies are well contrasted in the nitrogen map,
whereas the phosphorus content is low. Notably, there is
no evidence of small fibers or granules rich in phosphorus.
Such signals are always observed when RNA or DNA is
present, even as structures in the 2–10 nm range. These re-
sults indicate that the cores are mainly composed of pro-
tein.
 
The Core of the PML Nuclear Body Is a
Protein-based Structure
 
Qualitative analysis of such images (Fig. 2, D and E) indi-
cates that the core of the PML nuclear body is depleted in
nucleic acids. Fig. 3 shows high magnification images of a
PML nuclear body (Fig. 3, left,
 
 
 
phosphorous map, right,
nitrogen map). The presence of RNA or DNA in this
structure would likely resemble phosphorus-rich granules,
as seen in the core of the interchromatin granule clusters
and throughout the nucleoplasm (Hendzel et al., 1998,
1999), or more extended fibrils, reflecting noncompacted
nucleic acids (Hendzel et al., 1999). Such structures are not
apparent, even at high magnification (Fig. 3). To extend
the morphological analysis, we quantified the phosphorus
and nitrogen content in different regions around the PML
nuclear body (Fig. 3, B and D). The core of the PML nu-
clear body, a region corresponding to condensed chroma-
tin, a background region in the nucleoplasm, and a back-
ground outside of the cell comprised of the embedding
Figure 3. Quantification of phosphorus and nitrogen content of a PML nuclear body at high magnification. The three indicated areas
were used for quantification of phosphorus and nitrogen. The left region corresponds to chromatin, the middle region to nucleoplasm,
and the right region to the core of a PML nuclear body. A fourth region (not shown) corresponds to a region outside the cell, containing
only the embedding resin. The signal over the resin was used to normalize all images and was adjusted to the same value for each image.
Therefore, these represent background-stripped spectra on the basis of this normalization. The phosphorus map is shown in A and the
nitrogen map in C. Energy-loss spectra of these regions spanning the phosphorus L2,3 edge (B) and the nitrogen K edge (D) are pre-
sented at 10-eV intervals. Structures are represented as white objects on a black background. 
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resin alone (not shown) were delineated with masks. The
mean integrated signals from the energy-loss spectrum
spanning the phosphorus L
 
2,3 
 
and nitrogen K
 
 
 
edges were
measured over the regions delineated by the masks (Fig. 3,
B and D). No phosphorus or nitrogen can be detected in
the embedding resin, indicated by the flat line in both
spectra. The standard deviation in the phosphorus and ni-
trogen signal intensities was always 
 
,
 
2% of the mean for
the PML nuclear body, the chromatin, and the nucleo-
plasm. Error bars indicating these values would not show
outside of the symbols on the graphs. The masks for the
embedding resin, the chromatin, and the core of the PML
nuclear body are approximately equal in area, whereas the
mask for the nucleoplasm had to be smaller, 
 
z
 
0.25 of the
area of the others. However, the standard deviation of
the means of numerous small regions of the nucleoplasm
was also 
 
,
 
0.5%, indicating that differences in sampling be-
tween nucleoplasm and nuclear structures do not account
for the differences in element concentrations measured.
The energy-loss spectra of regions in the nucleus are con-
sistent with the presence of phosphorus, characterized by
the strong delayed edge above 150 eV. The phosphorus
content (155 eV) of the core of the PML nuclear body was
 
z
 
1.4% above the nucleoplasmic background, whereas the
chromatin was 16% above the nucleoplasmic background,
corresponding to a signal 11 times higher for the chroma-
tin compared with the PML nuclear body. In contrast, the
nitrogen signal (415 eV) for chromatin is 9% over the nu-
cleoplasm and the PML body core is 10% over the nucleo-
plasmic background. The phosphorus signal in the nucleo-
plasmic background is likely derived predominantly from
phosphorylated proteins. Because of a comparable phos-
phorus signal in the PML nuclear body core and the nucle-
oplasm, and the absence of morphologically recognizable
phosphorus-rich complexes, we conclude that the core of
this subnuclear structure does not contain nucleic acid
(DNA and RNA) and is composed only of protein.
 
Phosphorus-rich Fibers Are Present at the Periphery of 
the Core of the PML Nuclear Body
 
Although the use of thin sections (30 nm) is necessary for
quantitative elemental analysis by ESI (electron accelerat-
ing voltage of 80 kV), we have found that thicker sections
stained with uranyl acetate still contain qualitatively useful
elemental information (Boisvert, F.-M., preliminary ob-
servations). Thicker sections allow one to follow fibers
that would otherwise rapidly leave the plane of the section
if they are not parallel to the section. Fig. 4 shows consecu-
tive 90-nm sections through a PML nuclear body. The cen-
ter of the PML body core is characterized by a hole in the
nitrogen map (Fig. 4, 1, arrow). Blocks of condensed chro-
matin surrounding the core are evident in the phosphorus-
enhanced maps (Fig. 4, 1, 2, arrows; Fig. 3 A). Extended
thin fibers measuring as little as 2 nm in diameter are con-
sistently visualized at the immediate periphery of the core
of the PML nuclear body when imaged with high res-
olution (Fig. 5). Nascent RNA is the most abundant sub-
nuclear structure that has been identified in an extended
conformation (Malatesta et al., 1994), and it is likely,
therefore, that these phosphorus-rich fibers are RNA-
based.
Figure 4. Serial sections of 90-nm thickness of a PML nuclear
body stained with uranyl acetate. Images in the left column are
phosphorus-enhanced, recorded at 155 eV, and those in the right
column are nitrogen-enhanced, recorded at 415 eV. The middle
of the PML nuclear body is shown in section 1. The protein core
is visible in the nitrogen-enhanced image, and a hole on the core
is indicated with the arrow in the nitrogen-enhanced image. Ar-
rows in the phosphorus-enhanced images indicate blocks of con-
densed chromatin. Structures are represented as white objects on
a black background. The next section (2) still shows the protein
core, whereas section 3 is now out of the core of the nuclear
body. The last section (4) shows the chromatin closing back over
the structure. 
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Localization of Nascent RNA at the Periphery of the 
PML Nuclear Bodies
 
Our ESI analysis indicates that the core of the PML nu-
clear body is composed mainly of protein, whereas the pe-
riphery contains DNA and/or RNA. In a previous report
(LaMorte et al., 1998), the entire PML body was reported
to contain RNA, based on fluorescently labeled uridine in
permeabilized cells. To determine whether newly tran-
scribed RNA is present in the vicinity of PML bodies, we
chose to label unperturbed cells with FU. Incorporation of
FU in nascent RNA is rapid and specific and does not re-
quire a cell permeabilizing step. Signal visualized with an-
tibodies against halogenated nucleotides can be detected
throughout the nucleoplasm after two-minute pulses, with
increasing signal over time (Fig. 6, C, H, and M). Strong,
but less punctate, nucleolar labeling can also be seen after
ten minutes, concordant with the high level of transcrip-
tion therein. The diffuse nature of this signal causes an ap-
parent attenuation of the signal relative to the punctuate
foci found outside of the nucleolus in deconvolved optical
sections. Before deconvolution, the nucleolar signal ap-
pears dominant. This nucleolar signal indicates that the
penetration of the antibody and the FU is not inhibited by
dense, compartmentalized structures, such as the nucleo-
lus. To determine the relationship between PML nuclear
bodies and RNA synthesis and accumulation, we cola-
beled cells with anti-CBP NH
 
2
 
-terminal antibodies (Fig. 6,
B, G, and L, red) and anti-FU antibodies (Fig. 6, C, H, and
M, green) after 2-, 10-, and 60-min pulses of FU. After
only two minutes, most PML nuclear bodies have FU-
incorporated RNA on their peripheries. This FU incorpo-
ration appears as a small number of foci (between 1 and 3)
on the periphery of a PML nuclear body. When pulses
were extended to longer times, RNA is still seen on the
periphery in a small number of foci, and does not accumu-
late inside the structure as visualized by CBP labeling (Fig.
6, E, J, and O). The FU labeling is consistent with the ESI
data, leading us to conclude that the core of the PML nu-
clear body is a protein-dense structure where RNA syn-
thesis and RNA accumulation do not occur. Transcription
does appear to occur near the periphery of PML nuclear
bodies, but not within.
 
Highly Acetylated Chromatin Surrounds PML Nuclear 
Bodies, but Is Not Found Within
 
Phosphorus mapping by ESI and FU incorporation de-
tected by fluorescence microscopy indicated that there is
no nucleic acid in PML nuclear bodies. Nevertheless, we
wished to strengthen our conclusion that there is no chro-
matin within the PML nuclear body, but also to determine
whether transcription occurs on the periphery. For this ex-
periment, we imaged PML nuclear bodies by deconvolu-
tion of optical sections, using an antibody recognizing the
transcription-associated, highest acetylated species of his-
tone H3 (Fig. 6, Q and R; Boggs et al., 1996). As expected
from the FU incorporation experiments and ESI analysis,
the cores of PML nuclear bodies do not show any evidence
for the presence of highly acetylated euchromatin. All of
the PML nuclear bodies, however, are within one diame-
ter (250 nm) of a block of highly acetylated chromatin
(Fig. 6 S). Moreover, some PML nuclear bodies are associ-
ated with multiple blocks of acetylated chromatin (Fig. 6
T; also see blocks of chromatin surrounding the PML nu-
clear body in the phosphorus map in Fig. 3 A). Further
studies are required to determine whether transcription-
ally active chromatin is indeed functionally associated with
PML nuclear bodies, or whether the association is a ran-
dom event. For example, it would be necessary to deter-
mine whether specific gene sequences associate with the
periphery of PML nuclear bodies. From the ESI data and
from the absence of highly acetylated chromatin or DAPI-
stained chromatin within the core of the PML nuclear
body, we conclude that the core of the structure is not a
site of transcriptional activity.
 
Discussion
 
There has been an increasing interest in the PML nuclear
bodies in the past few years because of their involvement
in viral infection (Sternsdorf et al., 1997b; Maul, 1998) and
their disruption and disappearance in acute promyelocytic
leukemia (Borrow et al., 1990; de The et al., 1990, 1991;
Kakizuka et al., 1991; Dyck et al., 1994; Koken et al.,
1994). Whether this structure serves only as a storage site
for regulatory factors, functions as a site for transcription
by creating a suitable environment, or plays some other
role will only be determined as its structure and composi-
tion are characterized. In this study, we have addressed
several questions about the structure, organization, and
function of the PML nuclear body.
First, we have shown that the core of the PML nuclear
body is composed entirely, or almost entirely, of protein.
There is no detectable nucleic acid in the 250-nm-diam
core of the structure. This core is not a uniform sphere of
Figure 5. Thick section of a PML nuclear body, stained with ura-
nyl acetate, recorded at 415 eV. Extended fibers are observed
just outside the core of the PML nuclear body. Structures are
represented as white objects on a black background. These fibers
are  z2–4 nm in diameter, and are also phosphorus-rich (not
shown). 
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Figure 6. Digital deconvolution microscopy of SK-N cells pulsed with FU for 2 (A–E), 10 (F–J), or 60 (K–O) min. FU was labeled with
an anti-BrdU antibody (green, C, H, and M) and anti–CBP-NT antibody (red, B, G, and L). Merged images are shown in D, I, and N,
and a high magnification of one PML nuclear body for each time course is displayed in E, J, and O. DNA stained with DAPI shows the
nucleus of each cell (A, F, K, and P). Some cells were labeled with an antibody against the highest acetylated form of histone H3 (green,
R) to reveal transcriptionally active/competent chromatin. PML nuclear bodies were detected with an antibody against PML protein
(5E10) shown in Q. Images Q and R are merged to form S, and the indicated PML nuclear body is magnified in T. 
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protein, but rather has channels and pores throughout. Se-
rial sections (Fig. 4) indicate that the mass density of the
very center is much lower than the outer regions of the
core. Many proteins have been shown to localize to PML
nuclear bodies, such as the transcription regulatory factor
PML protein, the transcriptional coactivator CBP, and
other proteins, such as Sp100. It is likely that such compo-
nents of the PML nuclear body are localized in this core
structure, and the core represents a specialized component
of the karyoskeleton (Hendzel et al. 1999).
The second major finding in this paper is that the pro-
tein-based core is surrounded by blocks of chromatin that
are condensed to levels beyond the 30-nm fiber. In cross-
sections, phosphorus maps illustrate a discontinuous ring
of chromatin around the protein-based core, and by serial
sectioning, phosphorus maps demonstrate that the blocks
of chromatin completely surround the core. In future ex-
periments, we will investigate whether some of this chro-
matin is participating in transcriptional activity.
The third major finding relates to the PML body as a
site for RNA synthesis. Both ESI and long incubation
times in the presence of fluorescently detected label reveal
that the core of the structure always remains free of RNA.
Nevertheless, phosphorus-rich fibers that are morphologi-
cally more consistent with RNA than chromatin are ob-
served in the space between the protein core and the
blocks of chromatin. It remains to be shown whether the
apparent association of highly acetylated chromatin, FU
incorporation, and the RNA fibers reflect a functional re-
lationship to the PML nuclear body or reflect a random as-
sociation. It might be expected that the high levels of CBP,
located in PML nuclear bodies, would contribute to a fa-
vorable environment for chromatin remodeling and tran-
scriptional activity. The presence of nascent RNA at the
periphery of this structure is concordant with the observa-
tion by Ishov et al. (1997), who localized viral transcripts
next to this nuclear body.
Our conclusions differ dramatically from those of La-
Morte and coworkers (LaMorte et al., 1998). These authors
used EDTA-regressive staining technique, which prefer-
entially labels RNA (Bernhard, 1969), and fluorescein-
UTP incorporation in situ nuclear run-on experiments to
conclude that very high concentrations of RNA are local-
ized within the structure. Both experiments have limita-
tions. The specificity of the EDTA-regressive staining pro-
cedure is not absolute, and, in the case of structures of
unknown composition, cannot be interpreted to be RNA-
based solely on the presence of staining after the EDTA
chelation of uranium ions from chromatin (Bernhard,
1969). We report here that the core of the PML nuclear
body contains only nucleoplasmic background levels of
phosphorus and no discernible phosphorus-rich fibers.
This holds for all PML nuclear bodies observed and does
not characterize a small subset of these structures (La-
Morte et al., 1998). As a positive control for our observation
that the core contains little or no RNA, subnuclear do-
mains that are known to contain high amounts of RNA do
have high phosphorus signals when imaged by ESI. These
structures include 30-nm chromatin fibers, the nucleolus
(Fig. 2 D), interchromatin granule clusters (Hendzel et al.,
1998), or the Sam 68 nuclear bodies (Chen et al., 1999).
Because the sensitivity of these procedures has been
shown to be very high (Bazett-Jones and Hendzel, 1999;
Bazett-Jones et al., 1999; Hendzel et al., 1999), our results
rule out the possibility that the intense staining of these
structures using the EDTA-regressive staining method is
the result of an abundance of RNA within the structure.
Similarly, the nuclear run-on experiment, which shows la-
beling of the PML nuclear bodies, has a greater potential
for experimental artifacts than does the direct incorpora-
tion into RNA through addition of FU into the tissue cul-
ture medium.
We present a number of independent methods that
demonstrate an absence of: bulk chromatin; acetylated
chromatin; newly synthesized RNA; or phosphorus-rich
nucleic acids; in the core of the PML nuclear body. There-
fore, we conclude that it is highly unlikely that the PML
nuclear body represents a higher-order nuclear structure
that nucleates or aggregates around specific clusters of
transcriptionally active genes or even single, highly active
genes. Instead, the presence of transcription regulatory
factors within the PML nuclear body and the blocks of
chromatin and nascent RNA in the immediate vicinity of
the PML nuclear body, raise the importance of further ex-
perimentation to test whether these structures are respon-
sible for creating or establishing a transcriptional domain.
A nuclear-neighbor hypothesis for regulation of nuclear
events has been presented to explain a number of similar
relationships involving subnuclear domains (Schul et al.,
1998).
Subnuclear compartments that function to concentrate
regulatory factors and complexes may be important in
modulating gene expression (Schul et al., 1998). The inter-
chromatin granule cluster (IGC), for example, is able to
concentrate transcriptional coactivators in the protein-rich
core, and is surrounded by transcriptionally active chro-
matin (Hendzel et al., 1998). Indeed, the peripheries of
IGCs are sites of transcription of particular genes (Smith
et al., 1999). PML nuclear bodies, which, incidentally, are
generally associated with IGCs (Ishov et al., 1997), may
also serve to concentrate regulatory factors that service
transcriptional events on their surfaces. Genes that are im-
plicated in requiring PML nuclear bodies for expression
are early viral genes (Guldner et al., 1992; Chelbi-Alix et al.,
1995; Lavau et al., 1995; Grotzinger et al., 1996; Ishov et
al., 1997) and, possibly, genes important for immune func-
tion, including MHC class I and II (Kretsovali et al., 1998;
Zheng et al., 1998; Fontes et al., 1999).
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